Edge Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$250K Hold
3,152
0.02% 286
2018
Q1
$281K Sell
3,152
-12,329
-80% -$1.18M 0.03% 274
2017
Q4
$1.61M Buy
15,481
+1,858
+14% +$210K 0.16% 123
2017
Q3
$1.99M Buy
13,623
+124
+0.9% +$16.9K 0.22% 103
2017
Q2
$1.75M Sell
13,499
-366
-3% -$44.8K 0.2% 116
2017
Q1
$1.72M Buy
13,865
+3,204
+30% +$383K 0.21% 111
2016
Q4
$1.23M Buy
+10,661
New +$1.19M 0.16% 130

Other funds holding CELG

Edge Advisors's CELG Position: Q2 2018 in Review

Edge Advisors held its Celgene Corp (CELG) position steady in Q2 2018 at 3,152 shares worth $250K. The position accounts for 0.02% of the portfolio, ranked #286.

Edge Advisors first reported a position in CELG in Q4 2016 and has held it in 7 quarters since. The position peaked at $1.99M in Q3 2017. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

  • Edge Advisors held 3,152 shares of Celgene Corp worth $250K as of Q2 2018.
  • Edge Advisors left its Celgene Corp share count unchanged in Q2 2018.
  • Celgene Corp made up 0.02% of Edge Advisors's portfolio in Q2 2018, its #286 holding.
  • Edge Advisors first reported a position in Celgene Corp in Q4 2016 and has held it in 7 quarters since.
  • Edge Advisors's Celgene Corp position peaked at $1.99M in Q3 2017.
  • 1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on Edge Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.